【Event】The 7th Annual Meeting

The 7th Annual Meeting will be held as follows.
This year, the conference will again be held simultaneously at the venue and online.

*Registration on the day of the event has been closed.

Date and Time

Sunday, September 17, 2023
Opening at 11:00 a.m. (doors open at 10:30 a.m.) – Closing at 5:00 p.m.

*The General Meeting will be held before the Annual Conference (members only).

venue

Rihga Royal Hotel Osaka Tower Wing 3F “Korin-no-Ma”
*The venue has changed
5-3-68 Nakanoshima, Kita-ku, Osaka 530-0005
For access
For free shuttle bus from JR Osaka
For parking information

Greetings from the Representative Director

Greetings from the Representative Director

Representative Director Yoshimu Tanaka President, Tanaka Clinic, Jinzenkai Medical Corporation

The Intestinal Flora Transplantation Clinical Research Society of Japan is pleased to announce its 7th Annual Conference. We would like to express our gratitude for the support and cooperation of patients who have undergone transplantation, doctors and other medical professionals affiliated with the study group, supporting members, and the general public. Our research group has been the first private sector in Japan to systematically work on the transplantation of intestinal microflora. In May of this year, doctors belonging to this research group started a clinical study of “a novel fecal microbiota transplantation method using nanobubble water (NanoGAS® water)” (novel FMT method) for children with autism spectrum disorder aged 5 to 12 years, without using antimicrobial agents commonly used in conventional methods. THIS FMT METHOD IS BEING DEVELOPED AS A NEW METHOD THAT DOES NOT REQUIRE ADMINISTRATION OF ANTIMICROBIAL AGENTS OR INTESTINAL CLEANSING PRIOR TO FMT, WHICH HAS BEEN DONE IN PREVIOUS STUDIES, AND THAT USES A SMALL DOSE (ABOUT 1/1000 OF THE DOSE (NUMBER OF BACTERIA) USED IN THOSE STUDIES). TO DATE, THE METHOD HAS PRODUCED RESULTS NOT ONLY IN GASTROINTESTINAL DISEASES SUCH AS ULCERATIVE COLITIS AND IRRITABLE BOWEL SYNDROME, BUT ALSO IN ALLERGIC DISEASES SUCH AS ATOPIC DERMATITIS. IN THE FUTURE, WE WOULD LIKE TO PROMOTE THE CLINICAL VALIDATION OF THE INTESTINAL BACTERIA IN RELATION TO CANCER. WE WOULD LIKE TO ASK FOR YOUR GREAT SUPPORT AND COOPERATION.

Registration and Participation Fee

On-site registration is due by noon on Thursday, September 14.
Online registration is due by noon on Friday, September 15.
Please note that no cancellations will be accepted after the deadline for both on-site and online registration.

Transplant Patients Annual Meeting [On-site and Online Participation]
Transplant patients are invited by invitation only.
(If you are unable to attend in person, up to one proxy can attend free of charge.)
Please register by selecting on-site participation or online participation using this form.
Online participation is free for family members.

*Registration on the day of the event has been closed.

time schedule

*The content and order of presentations are subject to change.

*Registration on the day of the event has been closed.

Speakers

Intestinal Bacteria and Cancer

Future Clinical Research in the Intestinal Flora Transplantation Clinical Study Group - Cancer Initiatives

Representative Director Dr. Zen Tanaka
Jinzenkai Tanaka Clinic President

A link between intestinal bacteria and cancer has been pointed out, in part because both are mutually related to the human immune system. Some studies have suggested that an imbalance in the intestinal microbiota may lead to the development and progression of cancer, and that certain intestinal bacteria may hold the key. Based on the paper “Nutrients” published in 2021 by Dr. Zen Tanaka, the president of this study group, we will report on the latest cases and cancer from the viewpoint of intestinal microflora.

Case reports

A case of food intolerance showing improvement by intestinal flora transplantation

Dr. Yuichi Kawai
Medical Corporation Yuakai Cute Internal Medicine Clinic Chairman of the Board

The involvement of dysbiosis in many diseases has become apparent, and fecal microbiota transplantation (FMT) is being investigated for many diseases worldwide. Recently, it has also become clear that intestinal bacteria are involved in digestion and absorption by producing enzymes that break down various specific nutrients that cannot be produced by humans. FOOD INTOLERANCE IS “THE INABILITY TO PROPERLY DIGEST CERTAIN FOODS,” AND TREATMENT FOR THE ELIMINATION OF THE FOODS THAT PRODUCE THE INTOLERANCE FROM THE DIET IS OFTEN DIFFICULT IN THE MODERN DIET, AND THE SYMPTOMS AND THE DIFFICULTY IN MAINTAINING THE ELIMINATED FOODS IMPAIR THE QUALITY OF LIFE OF THE PATIENT. 　We report a case in which FMT improved the dysbiosis of a patient with dairy and meat intolerance, and after FMT, the patient no longer had diarrhea after consuming dairy and meat products.

Just the Right Intervention” for the Intestinal Environment Created by Intestinal Bacteria

This is box title

Makoto Shimizu
Symbiosis, Inc. Senior Researcher

Bacteria cover our bodies from the inside and outside. They are not well-liked, but they are only a small part of the pathogens, and most of them are a part of us, working as part of our metabolism and immune system. What is a healthy intestinal microflora? Can the intestinal microflora be changed? WHILE TAKING INTO ACCOUNT THE LATEST FINDINGS, THE STUDY GROUP WILL INTRODUCE ITS OWN FMT (INTESTINAL FLORA TRANSPLANTATION) TO ACHIEVE ITS GOAL.

Presentation of the results of joint research at Kobe Gakuin University

This is box title

Risako Morishita
Symbiosis, Inc.

We are collaborating to evaluate the fundamentals and applications of Nanobubble (NanoGAS®) in the pharmaceutical and medical fields starting in 2020. 　Various gases contained in air have various physiologically active effects on living organisms, but it is generally difficult to utilize gases for living organisms. Nanobubbles, which can hold gases in liquids for long periods of time, make it possible to “drink” gases. 　In this study, we examined the effect of drinking NanoGAS® hydrogen water, which contains hydrogen with antioxidant properties, on the reduction of oxidative stress and reported on the oral gas delivery capability of NanoGAS®.

Luncheon Seminar

Luncheon Seminar

Junko Kaba
Manager Sommelier, Restaurant Le Clos Group / Director, General Incorporated Association FUKURO

The Le Clos group of French restaurants, which has been in business for 23 years, is the setting. I want to work together with everyone to create a society where people with and without disabilities can be happy together.” The welfare office was opened in 2016 from the desire of the owner chef Kuroiwa. A variety of dishes and sweets made by a collaboration of professional chefs and users called cast members. We would like to share with you the joy of working with our sparkling cast members.

Keynote Speech (Online)

Brain Science Deciphering the Symptoms of Autism Spectrum Disorders

Dr. Tatsuya Koeda
Vice President, National Center for Child Health and Development
Professor Emeritus, Tottori University

　After graduating from the Faculty of Medicine at Tottori University in 1984, he studied at the Department of Pediatrics at Frei University as a Dutch government scholarship student, and became a professor at the Faculty of Education, Tottori University in 1998. He has served as a member of various councils of the central government from 2004 as a member of the Study Committee on Support for Persons with Developmental Disabilities, Ministry of Health, Labour and Welfare, to 2023 as a member of the Committee on Disability Policy, Cabinet Office. He is the author of many books, including “5-Year-Old Child Health Examination – Essentials of Medical Treatment and Guidance for Developmental Disorders.

ASD CLINICAL RESEARCH INTERIM REPORT

Specific Clinical Research Begins ~ The Challenge of Developing a Treatment for Autism Spectrum Disorders! ~.

Dr. Masahiko Shirotani
Luke’s Ashiya Clinic Director

THE PURPOSE OF THIS CLINICAL STUDY IS TO OPEN A NEW PATH TO THE TREATMENT OF AUTISM SPECTRUM DISORDER (ASD) USING A “NEW INTESTINAL FLORA TRANSPLANTATION (FMT) METHOD USING HYDROGEN NANOBUBBLE WATER”. THIS NEW FMT METHOD DOES NOT REQUIRE ANTIMICROBIAL ADMINISTRATION OR BOWEL CLEANSING, WHICH ARE COMMONLY USED WHEN PERFORMING FMT, AND ITS DOSAGE (NUMBER OF BACTERIA TO BE ADMINISTERED) IS LESS THAN 1/1000 OF THE CONVENTIONAL FMT METHOD, MAKING IT A MODERATE CONDITION FOR CHILDREN WITH ASD. In this presentation, we will report on the background of the specific clinical research and the mid-term results of the clinical research that started in May.

panel discussion

“Autism Spectrum Disorder (ASD) and the Possibility of Intestinal Flora Transplantation”
Introduction of testimonials from parents of children who have received transplants

Chairperson: Dr. Zen Tanaka (President, Jinzenkai Tanaka Clinic )
Dr. Masahiko Shirotani (Director, Luke’s Ashiya Clinic )
Dr. Reiko Haruna (Vice President, Haruna Clinic )
Dr. Yasuhito Mikawa (Director, Natural Art Clinic )* Online
Dr. Yuichi Kawai (President, Yuuakai Cutanei Clinic )
Kunihiro Kitamura, M.D. (President, Kitamura Clinic, Medical Corporation Kiwakai )

*Registration on the day of the event has been closed.